Amanta Healthcare: No Deviation in IPO Fund Utilization for Q3 FY27

Amanta Healthcare Limited has submitted its quarterly statement on the utilization of funds raised through its Initial Public Offer (IPO). The company confirms that there has been no deviation or variation in the use of proceeds for the quarter ended September 30, 2026. The funds were raised on September 9, 2025, amounting to ₹126 crore. The utilization was primarily for funding capital expenditure requirements for civil construction work and the purchase of equipment, plant, and machinery for new manufacturing lines at their Hariyala, Kheda facility, as well as for general corporate purposes. The Audit Committee and auditors have reviewed the statement and found no issues.